Scleroderma, Systemic: Clinical Trials

7 trials for Scleroderma, Systemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Terminated 7
Phase 23Terminated 3

Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiac Safe Transplants for Systemic Sclerosis
Rituximab, Fludarabine, Cyclophosphamide - Systemic Sclerosis, Scleroderma
Phase 2 / Phase 3TerminatedNorthwestern University92018-05-172020-08-12
Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Lenabasum 5 mg, Lenabasum 20 mg, Placebo oral capsule - Diffuse Cutaneous Systemic Sclerosis
Phase 3TerminatedCorbus Pharmaceuticals Inc.3652017-12-182021-03-29
Exparel as a Nerve Block for Severe Hand Pain
liposomal bupivacaine - CREST Syndrome, Peripheral Vascular Disease
Phase 2 / Phase 3TerminatedJose Soberon, MD132014-11-012024-05-21
A Clinical Trial for CTD-ILD Treatment
N-Acetylcysteine - Interstitial Lung Disease, Connective Tissue Disease
Phase 2 / Phase 3TerminatedUniversity of Michigan52011-12-012017-04-06
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Macitentan 3 mg, Macitentan 10 mg, Placebo - Digital Ulcers
Phase 3TerminatedActelion2652011-12-012025-02-04
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
Peripheral Blood Stem Cells, Cyclophosphamide, Mesna - Scleroderma, Systemic
Phase 3TerminatedNorthwestern University442011-09-152020-07-23
Tibial Delayed Healing Pivotal Clinical Trial
INFUSE/MASTERGRAFT, Autograft bone - Tibial Delayed Healing
Phase 3TerminatedMedtronic Spinal and Biologics232010-11-012015-01-21

Narrower conditions

Scleroderma, Diffuse (4)  ·  Arthritis, Rheumatoid (1)  ·  CREST Syndrome (1)  ·  Connective Tissue Diseases (1)  ·  Dermatomyositis (1)  ·  Fractures, Bone (1)  ·  Lung Diseases, Interstitial (1)  ·  Mixed Connective Tissue Disease (1)  ·  Peripheral Vascular Diseases (1)  ·  Polymyositis (1)  ·  Raynaud Disease (1)  ·  Scleroderma, Limited (1)  ·  Sjogren's Syndrome (1)  ·  digital ulcers (1)

Broader conditions

Skin Diseases (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Connective Tissue Diseases (6)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Calcinosis (1)  ·  Calcium Metabolism Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Deglutition Disorders (1)  ·  Digestive System Diseases (1)  ·  Dry Eye Syndromes (1)  ·  Embolism and Thrombosis (1)  ·  Esophageal Diseases (1)  ·  Esophageal Motility Disorders (1)

Interventions

Cyclophosphamide (2)  ·  Filgrastim (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Mesna (2)  ·  Methylprednisolone (2)  ·  Methylprednisolone Hemisuccinate (2)  ·  fludarabine (2)  ·  fludarabine phosphate (2)  ·  thymoglobulin (2)  ·  Acetylcysteine (1)  ·  Antilymphocyte Serum (1)  ·  Immunoglobulins, Intravenous (1)  ·  Methylprednisolone Acetate (1)  ·  Octagam (1)  ·  Rituximab (1)

Sponsors

Northwestern University (2)  ·  Actelion (1)  ·  Corbus Pharmaceuticals Inc. (1)  ·  Jose Soberon, MD (1)  ·  Medtronic Spinal and Biologics (1)  ·  University of Michigan (1)

Countries

United States (6)  ·  Australia (1)  ·  Canada (1)  ·  Germany (1)  ·  Israel (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Richard Burt, MD (2)  ·  Chris Denton, MD (1)  ·  Jose Soberon, MD (1)  ·  Robert Spiera, MD (1)

Results publications

PMID 27163986, PMID 32612255